NF-κB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells

Acta Pharmacologica Sinica

Volumn 29, Issue 3, 2008, Pages 333-340

  Qiao, Ling ^a   Zhao, Tie Jun ^a   Wang, Feng Ze ^a   Shan, Chang Liang ^a   Ye, Li Hong ^a   Zhang, Xiao Dong ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Breast cancer; Hepatoma; Mesenchymal stem cells; NF B

Indexed keywords

BROXURIDINE; I KAPPA B ALPHA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MESENCHYMAL STEM CELL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TUMOR CELL; BREAST TUMOR; CULTURE MEDIUM; DOWN REGULATION; DRUG EFFECT; FEMALE; FETUS; GENETICS; LIVER TUMOR; METABOLISM; PLASMID; REPORTER GENE; TIME; TUMOR CELL LINE;

BREAST NEOPLASMS; BROMODEOXYURIDINE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; FEMALE; FETUS; FLOW CYTOMETRY; GENES, REPORTER; HUMANS; LIVER NEOPLASMS; LUCIFERASES; MESENCHYMAL STEM CELLS; NF-KAPPA B; PLASMIDS; TIME FACTORS;

EID: 39849083006     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00751.x     Document Type: Article

References (38)

1. Omuro Y, Matsumoto G, Sasaki T, Tanaka Y, Maeda Y, Sakamaki H, et al. Regression of an unresectable pancreatic tumor following non-myeloablative allogeneic peripheral-blood stem-cell transplantation. Bone Marrow Transplant 2003 31 : 943 5.
2. Hentschke P, Barkholt L, Uzunel M, Mattsson J, Wersall P, Pisa P, et al. Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplant 2003 31 : 253 61.
3. Renga M, Pedrazzoli P, Siena S. Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumors. Ann Oncol 2003 14 : 1177 84.
4. Tabatabai G, Bahr O, Mohle R, Eyupoglu IY, Boehmler AM, Wischhusen J, et al. Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain 2005 128 : 2200 11.
5. Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R, et al. PEX-Producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 2005 11 : 5965 70.
6. Yuan X, Hu J, Belladonna ML, Black KL, Yu JS. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res 2006 66 : 2630 8.
7. Wulf GG, Chapuy B, Trumper L. Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives. Med Klin (Munich) 2006 101 : 408 13.
8. Chen XC, Wang R, Zhao X, Wei YQ, Hu M, Wang YS, et al. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs. Carcinogenesis 2006 27 : 2434 41.
9. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, et al. Human bone marrow - derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005 65 : 3307 18.
10. Hung SC, Deng WP, Yang WK, Liu RS, Lee CC, Su TC, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005 11 : 7749 56.
11. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004 96 : 1593 603.
12. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II., et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006 203 : 1235 47.
13. Ringden O, Le Blanc K. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. APMIS 2005 113 : 813 30.
14. Livraghi T, Meloni F, Frosi A, Lazzaroni S, Bizzarri TM, Frati L, et al. Treatment with stem cell differentiation stage factors of intermediate-advanced hepatocellular carcinoma: an open randomized clinical trial. Oncol Res 2005 15 : 399 408.
15. Qiao L, Xu Z, Tan X, Ye L, Zhang X. Investigation of inhibition of Wnt/β-catenin pathway in breast cancer cells mediated by Dkk-1 released from human mesenchymal stem cells. Prog Biochem Biophys 2007 34 : 702 8.
16. Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM. Diverse effects of zinc on NF-κB and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis 2006 27 : 1980 90.
17. Karin M. Nuclear factor-κB in cancer development and progression. Nature 2006 441 : 431 6.
18. Yao J, Duan L, Fan M, Wu X. NF-κB signaling pathway is involved in growth inhibition, G2/M arrest and apoptosis induced by trichostatin A in human tongue carcinoma cells. Pharmacol Res 2006 54 : 406 13.
19. Palona I, Namba H, Mitsutake N, Starenki D, Podtcheko A, Sedliarou I, et al. BRAFV600E promotes invasiveness of thyroid cancer cells through NF-κB activation. Endocrinology 2006 147 : 5699 705.
20. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 2001 107 : 241 6.
21. Kokura S, Yoshida N, Sakamoto N, Ishikawa T, Takagi T, Higashihara H, et al. The radical scavenger edaravone enhances the anti-tumor effects of CPT-11 in murine colon cancer by increasing apoptosis via inhibition of NF-κB. Cancer Lett 2005 229 : 223 33.
22. Poma P, Notarbartolo M, Labbozzetta M, Sanguedolce R, Alaimo A, Carina V, et al. Antitumor effects of the novel NF-KB inhibitor dehydroxymethyl- epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production. Int J Oncol 2006 28 : 923 30.
23. Luo JL, Kamata H, Karin M. IKK/NF-κB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest 2005 115 : 2625 32.
24. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr., Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol 2000 20 : 1626 38.
25. Nair AS, Shishodia S, Ahn KS, Kunnumakkara AB, Sethi G, Aggarwal BB. Deguelin, an Akt inhibitor, suppresses IκBα kinase activation leading to suppression of NF-κB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. J Immunol 2006 177 : 5612 22.
26. Ahn KS, Sethi G, Aggarwal BB. Embelin, an inhibitor of XIAP, blocks nuclear factor-κB (NF-κB) signaling pathway leading to suppression of NF-κB-regulated anti-apoptotic and metastatic gene products. Mol Pharmacol 2007 71 : 209 19.
27. Zhao Z, Liao L, Cao Y, Jiang X, Zhao RC. Establishment and properties of fetal dermis-derived mesenchymal stem cell lines: plasticity in vitro and hematopoietic protection in vivo. Bone Marrow Transplant 2005 36 : 355 65.
28. Zhang XD, Xu ZL, Ye LH, Dong N, Zhao CH, Cai B, et al. Isolation and identification of mesenchymal stem cell derived from human fetal bone marrow. Acta Scientiarum Naturalium Universitatis Nankaiensis 2006 39 : 107 10.
29. Ye LH, Wu LY, Guo W, Ma HT, Zhang X. Screening of a sub-clone of human breast cancer cells with high metastasis potential. Zhonghua Yixue Zazhi 2006 86 : 61 5.
30. + yeast strains. Nucleic Acids Res 2001 29 : 1433 42.
31. Plas E, Carroll VA, Jilch R, Simak R, Mihaly J, Melchior S, et al. Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer. Cytometry 2001 46 : 184 9.
32. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005 434 : 843 50.
33. Varga AC, Wrana JL. The disparate role of BMP in stem cell biology. Oncogene 2005 24 : 5713 21.
34. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW, et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006 442 : 823 6.
35. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006 66 : 4553 7.
36. Huang TT, Miyamoto S. Postrepression activation of NF-κB requires the amino-terminal nuclear export signal specifc to IκBα. Mol Cell Biol 2001 21 : 4737 47.
37. La Porta CA, Comolli R. PKC-dependent modulation of IκBα-NF- κB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells. Anticancer Res 1998 18 : 2591 7.
38. Mogensen TH, Melchjorsen J, Höllsberg P, Paludan SR. Activation of NF-κB in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-β-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and Iκβ kinase. J Immunol 2003 170 : 6224 33.